Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020380
Company: GALDERMA LABS LP
Company: GALDERMA LABS LP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DIFFERIN | ADAPALENE | 0.1% | GEL;TOPICAL | Over-the-counter | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/31/1996 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
06/14/2022 | SUPPL-21 | Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020380Orig1s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/020380Orig1s021ltr.pdf | |
03/23/2018 | SUPPL-13 | Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020380Orig1s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020380Orig1s013ltr.pdf | |
05/19/2017 | SUPPL-11 | Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020380Orig1s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020380Orig1s011ltr.pdf | |
07/08/2016 | SUPPL-10 | Efficacy-Rx To OTC Switch |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020380Orig1s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020380Orig1s010ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/020380s10_toc.cfm | |
09/05/2007 | SUPPL-4 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
06/14/2022 | SUPPL-21 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020380Orig1s021lbl.pdf | |
03/23/2018 | SUPPL-13 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020380Orig1s013lbl.pdf | |
05/19/2017 | SUPPL-11 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020380Orig1s011lbl.pdf | |
07/08/2016 | SUPPL-10 | Efficacy-Rx To OTC Switch | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020380Orig1s010lbl.pdf |
DIFFERIN
The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.
GEL;TOPICAL; 0.1%
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | Application No. | Company |
---|---|---|---|---|---|---|---|
ADAPALENE | ADAPALENE | 0.1% | GEL;TOPICAL | Over-the-counter | No | 091314 | GLENMARK PHARMS INC |
ADAPALENE | ADAPALENE | 0.1% | GEL;TOPICAL | Over-the-counter | No | 091314 | GLENMARK PHARMS INC |
ADAPALENE | ADAPALENE | 0.1% | GEL;TOPICAL | Over-the-counter | No | 090962 | P AND L |
ADAPALENE | ADAPALENE | 0.1% | GEL;TOPICAL | Over-the-counter | No | 215940 | TARO |
DIFFERIN | ADAPALENE | 0.1% | GEL;TOPICAL | Over-the-counter | Yes | 020380 | GALDERMA LABS LP |